NOVIT, L.P. 4
4 · Cyclo Therapeutics, Inc. · Filed Sep 2, 2020
Insider Transaction Report
Form 4
NOVIT, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2020-08-27+10,000,000→ 21,517,582 total - Purchase
Warrant to Purchase Common Stock
2020-08-27+10,000,000→ 10,000,000 totalExercise: $0.15From: 2020-08-27Exp: 2027-08-27→ Common Stock (10,000,000 underlying)
Footnotes (2)
- [F1]The reported securities consist of 10,000,000 "Units" purchased by the reporting person for $0.10 per Unit. Each Unit consists of one share of Common Stock and a warrant to purchase one share of Common Stock.
- [F2]Represents securities directly owned by Novit, L.P. ("Novit"). Each of the other Reporting Persons are indirect beneficial owners of such securities as follows: Novit U.S., Inc. is the general partner of Novit, and Katarzyna Kusmierz is the trustee of the NAP Trust and VN Trust, which indirectly own all of the outstanding partnership interests in Novit.